These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30030068)

  • 1. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
    Shiha G; Metwally AM; Soliman R; Elbasiony M; Mikhail NNH; Easterbrook P
    Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):778-789. PubMed ID: 30030068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
    Shiha G; Soliman R; Mikhail NNH; Easterbrook P
    J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals.
    Shiha G; Soliman R; Mikhail NNH; Easterbrook P
    J Hepatol; 2021 Feb; 74(2):303-311. PubMed ID: 32931878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.
    Waked I; Shiha G; Qaqish RB; Esmat G; Yosry A; Hassany M; Soliman R; Mohey MA; Allam N; Zayed N; Asselah T; Hall C; Redman R; Mobashery N; Doss W
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):36-44. PubMed ID: 28404110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt.
    Shiha G; Soliman R; Serwah A; Mikhail NNH; Asselah T; Easterbrook P
    J Viral Hepat; 2020 Jun; 27(6):593-601. PubMed ID: 31999866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal.
    Lin YC; Chiu WN; Chang TS; Huang TJ; Chen MY
    J Nurs Scholarsh; 2020 Mar; 52(2):128-135. PubMed ID: 31750620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial.
    Morris MD; McDonell C; Luetkemeyer AF; Thawley R; McKinney J; Price JC
    JAMA Netw Open; 2023 Oct; 6(10):e2338792. PubMed ID: 37862013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sofosbuvir, Pegylated Interferon and Ribavirin in the Treatment of an Egyptian Cohort with Hepatitis C Virus Infection in Real-Life Clinical Practice.
    Abd-Elsalam S; Badawi R; Elnawasany S; Yousef M; Mansour L; Hawash N; Elkhouly RA; Soliman S; Selim A; Kobtan A; Elfert A
    Infect Disord Drug Targets; 2019; 19(2):179-184. PubMed ID: 30207250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass screening for hepatitis B and C in Southern Upper Egypt.
    Soliman G; Elzalabany MS; Hassanein T; Miller FD
    BMC Public Health; 2019 Oct; 19(1):1326. PubMed ID: 31640639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide hepatitis C virus screening and treatment of adolescents in Egyptian schools.
    Kamal E; Asem N; Hassany M; Elshishiney G; Abdel-Razek W; Said H; Abdel Hamid S; Essam T; Rehan A; Salah A; Saad T; Shawky N; Mostafa A; Omar Y; Ammar I; Saeed R; AbdAllah M; Jabbour J; Hashish A; Bastawy S; El Qareh N; Gamaleldin N; Kabil K; Doss W; El-Sayed MH; Zaid H
    Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):658-665. PubMed ID: 35489364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022.
    Kandeel A; Fahim M; Abukamar S; BahaaEldin H; Abuelsood H; Samy S; Deghedy O; Sheta A; Naguib A; El Guindy N; Youssef A; Kamel R; Afifi S; El-Kassas M; Abdelghaffar K
    Liver Int; 2024 Apr; 44(4):955-965. PubMed ID: 38291807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt.
    Mostafa A; Shimakawa Y; Medhat A; Mikhail NN; Chesnais CB; Arafa N; Bakr I; El Hoseiny M; El-Daly M; Esmat G; Abdel-Hamid M; Mohamed MK; Fontanet A
    J Hepatol; 2016 Jun; 64(6):1240-6. PubMed ID: 26921686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents.
    Yousif MM; Elsadek Fakhr A; Morad EA; Kelani H; Hamed EF; Elsadek HM; Zahran MH; Fahmy Afify A; Ismail WA; Elagrody AI; Ibrahim NF; Amer FA; Zaki AM; Sadek AMEM; Shendi AM; Emad G; Farrag HA
    Infez Med; 2018 Sep; 26(3):237-243. PubMed ID: 30246766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt.
    Kamel MA; Miller FD; el Masry AG; Zakaria S; Khattab M; Essmat G; Ghaffar YA
    Ann Trop Med Parasitol; 1994 Oct; 88(5):501-9. PubMed ID: 7979640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.